Stay up to date with the latest news and events from the NIHR Manchester Biomedical Research Centre.
Nearly three quarters of new non-cancer pain opioid prescriptions were for patients with musculoskeletal conditions, despite limited evidence of the drug’s efficacy, according to the largest UK study of its kind.
Continue reading full article: Most non-cancer pain opioid prescriptions are for musculoskeletal conditions, study finds
For our PhDs in Focus blog series, Moe Zandy outlines how their Manchester BRC PhD project is investigating the risk of developing mental health conditions among children and young people who have been diagnosed with cancer, as part of the Living With and Beyond Cancer theme.
Continue reading full article: PhDs in Focus: Understanding the risk of developing mental health conditions among children and young people after a cancer diagnosis
For our PhDs in Focus blog series, Christina Diomatari outlines how their Manchester BRC PhD project aims to improve the safety of opioid use for patients with musculoskeletal conditions and those recovering from orthopaedic surgery, as part of the Rheumatic and Musculoskeletal Diseases theme.
Continue reading full article: PhDs in Focus: Enhancing opioid safety – Predicting adverse outcomes in musculoskeletal and post-surgery patients
For our PhDs in Focus blog series, Katie Dixon shares how their Manchester BRC PhD project focuses on the development of an intervention aimed at helping people make informed decisions about small-cell lung cancer treatment, as part of the Cancer Advanced Radiotherapy theme.
Continue reading full article: PhDs in Focus: Treatment decision-making in a complex cancer setting
A Manchester BRC-funded study has shown that a simple system, called the Manchester Score, can identify more breast cancer patients who are eligible for testing for inherited faulty genes that can cause breast cancer.
Continue reading full article: Manchester researchers identify system that can detect more breast cancer patients eligible for testing for cancer risk genes
Researchers at The University of Manchester in collaboration with Manchester University NHS Foundation Trust are launching a new Cystic Fibrosis Innovation Hub to accelerate the development of new tests and treatment approaches for lung infections.
Continue reading full article: New Cystic Fibrosis Innovation Hub in Manchester to develop pioneering tests and treatments for lung infections
Low dose morphine has the potential to treat chronic cough in people with idiopathic pulmonary fibrosis, according to new research from NIHR Manchester BRC and NIHR Imperial BRC.
Continue reading full article: Low dose morphine shows promise as effective treatment for chronic cough in people with idiopathic pulmonary fibrosis
Senior Research Fellow, Tunde Oremulé shares how outstanding teamwork has accelerated research aimed to widen access to specialist ear healthcare and improve patients' experiences.
Continue reading full article: Planned for a marathon, but it turned into a sprint – A blog by Tunde Oremulé, ENT Registrar